Valentina Milazzo

Valentina Milazzo

Auto-generated profile, based on publicly available information

Valentina Milazzo

Intensive Cardiac Care Unit, Centro Cardiologico Monzino, I.R.C.C.S., Milan, Italy

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
Giancarlo MarenziGiancarlo Marenzi
Giancarlo Marenzi
MMManuela Muratori
Manuela Muratori
ECEugenio R. Cosentino
Eugenio R. Cosentino
ERElisa R. Rinaldi
Elisa R. Rinaldi
VDValeria Donghi
Valeria Donghi
PAPiergiuseppe Agostoni
Piergiuseppe Agostoni

30 January 2018 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
Giancarlo MarenziGiancarlo Marenzi
Giancarlo Marenzi
NCNicola Cosentino
Nicola Cosentino
VMValentina Milazzo
Valentina Milazzo
MMMonica De Metrio
Monica De Metrio
MCMilena Cecere
Milena Cecere
ABAntonio L. Bartorelli
Antonio L. Bartorelli
OBJECTIVE Acute hyperglycemia is a powerful predictor of poor prognosis in acute myocardial infarction (AMI), particularly in patients without diabetes. This emphasizes the importance of an acute glycemic rise rather than glycemia level at admission alone. We investigated in AMI whether the combined evaluation of acute and chronic glycemic levels, as compared with admission glycemia alone, may have a better prognostic value. RESEARCH DESIGN AND METHODS We prospectively measured admission glycemia and estimated average chronic glucose levels (mg/dL) by the following formula: [(28.7 × glycosylated hemoglobin %) − 46.7], and calculated the acute-to- chronic (A/C) glycemic ratio in 1,553 consecutive AMI patients (mean ± SD age 67 ± 13 years). The primary end point was the combination of in-hospital mortality, acute pulmonary edema, and cardiogenic shock. RESULTS The primary end point rate increased in parallel with A/C glycemic ratio tertiles (5%, 8%, and 20%, respectively; P for trend <0.0001). A parallel increase was observed in troponin I peak value (15 ± 34 ng/mL, 34 ± 66 ng/mL, and 68 ± 131 ng/mL; P < 0.0001). At multivariable analysis, A/C glycemic ratio remained an independent predictor of the primary end point and of troponin I peak value, even after adjustment for major confounders. At reclassification analyses, A/C glycemic ratio showed the best prognostic power in predicting the primary end point as compared with glycemia at admission in the entire population (net reclassification improvement 12% [95% CI 4–20%]; P = 0.003) and, particularly, in patients with diabetes (27% [95% CI 14–40%]; P < 0.0001). CONCLUSIONS In AMI patients with diabetes, A/C glycemic ratio is a better predictor of in-hospital morbidity and mortality than glycemia at admission.

1 March 2013 in The American Journal of Cardiology
Verified
Journal Article
Closed access
Giancarlo MarenziGiancarlo Marenzi
Giancarlo Marenzi
ACAngelo Cabiati
Angelo Cabiati
SBSilvio V. Bertoli
Silvio V. Bertoli
EAEmilio Assanelli
Emilio Assanelli
IMIvana Marana
Ivana Marana
ABAntonio L. Bartorelli
Antonio L. Bartorelli

1 January 2017 in World Journal of Cardiology
Verified
Journal Article
Open access
VMValentina Milazzo
Valentina Milazzo
MMMonica De Metrio
Monica De Metrio
NCNicola Cosentino
Nicola Cosentino
Giancarlo MarenziGiancarlo Marenzi
Giancarlo Marenzi
ETElena Tremoli
Elena Tremoli
Vitamin D deficiency is a prevalent condition, cutting across all ethnicities and among all age groups, and occurring in about 30%-50% of the population. Besides vitamin D established role in calcium homeostasis, its deficiency is emerging as a new risk factor for coronary artery disease. Notably, clinical investigations have suggested that there is an association between hypovitaminosis D and acute myocardial infarction (AMI). Not only has it been linked to incident AMI, but also to increased morbidity and mortality in this clinical setting. Moreover, vitamin D deficiency seems to predispose to recurrent adverse cardiovascular events, as it is associated with post-infarction complications and cardiac remodeling in patients with AMI. Several mechanisms underlying the association between vitamin D and AMI risk can be involved. Despite these observational and mechanistic data, interventional trials with supplementation of vitamin D are controversial. In this review, we will discuss the evidence on the association between vitamin D deficiency and AMI, in terms of prevalence and prognostic impact, and the possible mechanisms mediating it. Further research in this direction is warranted and it is likely to open up new avenues for reducing the risk of AMI.

1 May 2015 in Medicine
Verified
Journal Article
Open access
MMMonica De Metrio
Monica De Metrio
VMValentina Milazzo
Valentina Milazzo
MRMara Rubino
Mara Rubino
ACAngelo Cabiati
Angelo Cabiati
MMMarco Moltrasio
Marco Moltrasio
Giancarlo MarenziGiancarlo Marenzi
Giancarlo Marenzi
Deficiency in 25-hydroxyvitamin D (25[OH]D), the main circulating form of vitamin D in blood, could be involved in the pathogenesis of acute coronary syndromes (ACS). To date, however, the possible prognostic relevance of 25 (OH)D deficiency in ACS patients remains poorly defined. The purpose of this prospective study was to assess the association between 25 (OH)D levels, at hospital admission, with in-hospital and 1-year morbidity and mortality in an unselected cohort of ACS patients. We measured 25 (OH)D in 814 ACS patients at hospital presentation. Vitamin D serum levels >30 ng/mL were considered as normal; levels between 29 and 21 ng/mL were classified as insufficiency, and levels < 20 ng/mL as deficiency. In-hospital and 1-year outcomes were evaluated according to 25 (OH)D level quartiles, using the lowest quartile as a reference. Ninety-three (11%) patients had normal 25 (OH)D levels, whereas 155 (19%) and 566 (70%) had vitamin D insufficiency and deficiency, respectively. The median 25 (OH)D level was similar in ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) patients (14.1 [IQR 9.0–21.9] ng/mL and 14.05 [IQR 9.1–22.05] ng/mL, respectively; P = .88). The lowest quartile of 25 (OH)D was associated with a higher risk for several in-hospital complications, including mortality. At a median follow-up of 366 (IQR 364–379) days, the lowest quartile of 25 (OH)D, after adjustment for the main confounding factors, remained significantly associated to 1-year mortality (P < .01). Similar results were obtained when STEMI and NSTEMI patients were considered separately. In ACS patients, severe vitamin D deficiency is independently associated with poor in-hospital and 1-year outcomes. Whether low vitamin D levels represent a risk marker or a risk factor in ACS remains to be elucidated.

1 December 2015 in The American Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
Giancarlo MarenziGiancarlo Marenzi
Giancarlo Marenzi
NCNicola Cosentino
Nicola Cosentino
SCSarah Cortinovis
Sarah Cortinovis
VMValentina Milazzo
Valentina Milazzo
MRMara Rubino
Mara Rubino
ABAntonio Bartorelli
Antonio Bartorelli